Cargando…

Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center

BACKGROUND: American Indian/Alaska Native (AI/AN) people suffer substantially higher rates of invasive pneumococcal disease (IPD) than the general US population. We evaluated antimicrobial prescribing data and their association with non-susceptibility in Streptococcus pneumoniae causing IPD in AI/AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Ryan W., Wenger, Jay, Bulkow, Lisa, Bruce, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867749/
https://www.ncbi.nlm.nih.gov/pubmed/24358456
http://dx.doi.org/10.3402/ijch.v72i0.22297
_version_ 1782296354036383744
author Stevens, Ryan W.
Wenger, Jay
Bulkow, Lisa
Bruce, Michael G.
author_facet Stevens, Ryan W.
Wenger, Jay
Bulkow, Lisa
Bruce, Michael G.
author_sort Stevens, Ryan W.
collection PubMed
description BACKGROUND: American Indian/Alaska Native (AI/AN) people suffer substantially higher rates of invasive pneumococcal disease (IPD) than the general US population. We evaluated antimicrobial prescribing data and their association with non-susceptibility in Streptococcus pneumoniae causing IPD in AI/AN people between 1992 and 2009. METHODS: Antimicrobial use data were gathered from the electronic patient management system and included all prescriptions dispensed to Alaska Native patients aged 5 years and older from outpatient pharmacies at the Alaska Native Medical Center (ANMC). Antimicrobial susceptibility data were gathered from pneumococcal isolates causing IPD among Anchorage Service Unit AI/AN residents aged 5 years and older. Data were restricted to serotypes not contained in the pneumococcal vaccine (PCV7). RESULTS: Over the study period, overall antimicrobial prescribing increased 59% (285/1,000 persons/year in 1992 to 454/1,000 persons per year in 2009, p<0.001). Trimethoprim/sulfamethoxazole prescribing increased (43/1,000 persons/year in 1992 to 108/1,000 persons/year in 2009, p<0.001) and non-susceptibility to trimethoprim/sulfamethoxazole in AI/AN patients ≥5 years of age increased in non-PCV7 serotypes (0–12%, p<0.05). Similarly, prescribing rates increased for macrolide antibiotics (46/1,000 persons/year in 1992 to 84/1,000 persons/year in 2009, p<0.05). We observed no statistically significant change over time in erythromycin non-susceptibility among non-PCV7 serotypes in AI/AN patients aged 5 years or greater (0–7%, p=0.087). CONCLUSION: Antimicrobial prescribing patterns of some antibiotics in the AI/AN population corresponded to increased antimicrobial resistance in clinical isolates. This study highlights the on-going threat of antimicrobial resistance, the critical importance of judicious prescribing of antibiotics and the potential utility of prescribing data for addressing this issue.
format Online
Article
Text
id pubmed-3867749
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Co-Action Publishing
record_format MEDLINE/PubMed
spelling pubmed-38677492013-12-19 Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center Stevens, Ryan W. Wenger, Jay Bulkow, Lisa Bruce, Michael G. Int J Circumpolar Health Original Research Article BACKGROUND: American Indian/Alaska Native (AI/AN) people suffer substantially higher rates of invasive pneumococcal disease (IPD) than the general US population. We evaluated antimicrobial prescribing data and their association with non-susceptibility in Streptococcus pneumoniae causing IPD in AI/AN people between 1992 and 2009. METHODS: Antimicrobial use data were gathered from the electronic patient management system and included all prescriptions dispensed to Alaska Native patients aged 5 years and older from outpatient pharmacies at the Alaska Native Medical Center (ANMC). Antimicrobial susceptibility data were gathered from pneumococcal isolates causing IPD among Anchorage Service Unit AI/AN residents aged 5 years and older. Data were restricted to serotypes not contained in the pneumococcal vaccine (PCV7). RESULTS: Over the study period, overall antimicrobial prescribing increased 59% (285/1,000 persons/year in 1992 to 454/1,000 persons per year in 2009, p<0.001). Trimethoprim/sulfamethoxazole prescribing increased (43/1,000 persons/year in 1992 to 108/1,000 persons/year in 2009, p<0.001) and non-susceptibility to trimethoprim/sulfamethoxazole in AI/AN patients ≥5 years of age increased in non-PCV7 serotypes (0–12%, p<0.05). Similarly, prescribing rates increased for macrolide antibiotics (46/1,000 persons/year in 1992 to 84/1,000 persons/year in 2009, p<0.05). We observed no statistically significant change over time in erythromycin non-susceptibility among non-PCV7 serotypes in AI/AN patients aged 5 years or greater (0–7%, p=0.087). CONCLUSION: Antimicrobial prescribing patterns of some antibiotics in the AI/AN population corresponded to increased antimicrobial resistance in clinical isolates. This study highlights the on-going threat of antimicrobial resistance, the critical importance of judicious prescribing of antibiotics and the potential utility of prescribing data for addressing this issue. Co-Action Publishing 2013-12-17 /pmc/articles/PMC3867749/ /pubmed/24358456 http://dx.doi.org/10.3402/ijch.v72i0.22297 Text en © 2013 Ryan W. Stevens et al. http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Article
Stevens, Ryan W.
Wenger, Jay
Bulkow, Lisa
Bruce, Michael G.
Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
title Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
title_full Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
title_fullStr Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
title_full_unstemmed Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
title_short Streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the Alaska Native Medical Center
title_sort streptococcus pneumoniae non-susceptibility and outpatient antimicrobial prescribing rates at the alaska native medical center
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867749/
https://www.ncbi.nlm.nih.gov/pubmed/24358456
http://dx.doi.org/10.3402/ijch.v72i0.22297
work_keys_str_mv AT stevensryanw streptococcuspneumoniaenonsusceptibilityandoutpatientantimicrobialprescribingratesatthealaskanativemedicalcenter
AT wengerjay streptococcuspneumoniaenonsusceptibilityandoutpatientantimicrobialprescribingratesatthealaskanativemedicalcenter
AT bulkowlisa streptococcuspneumoniaenonsusceptibilityandoutpatientantimicrobialprescribingratesatthealaskanativemedicalcenter
AT brucemichaelg streptococcuspneumoniaenonsusceptibilityandoutpatientantimicrobialprescribingratesatthealaskanativemedicalcenter